Login / Signup

Letter to the editor: Circulating thrombospondin-2 as a biomarker in patients with NAFLD with and without diabetes-Are we convinced yet?

Chi Ho LeeDavid T W LuiKaren S L Lam
Published in: Hepatology (Baltimore, Md.) (2022)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • weight loss